Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Yujiro, Nishioka"'
Autor:
Maciej Krasnodebski, Bradford J. Kim, Steven H Wei, Jenilette D Velasco, Yujiro Nishioka, Jean Nicolas Vauthey
Publikováno v:
Surgery in Practice and Science, Vol 3, Iss , Pp 100021- (2020)
Colorectal liver metastasis (CLM) occurs in a significant number of patients with colorectal cancer. Over several decades, surgical methods and chemotherapy improved, making it possible to extend the life of CLM patients. Currently, the multitude of
Externí odkaz:
https://doaj.org/article/9f7e565bee1d479eb7eb7fad1ca233a8
Autor:
Yukinori Ozaki, Junichi Shindoh, Wataru Gonoi, Yujiro Nishioka, Chihiro Kondoh, Yuko Tanabe, Shuichiro Matoba, Hiroya Kuroyanagi, Masaji Hashimoto, Toshimi Takano
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Regorafenib is a multi-kinase inhibitor, which was shown to be effective for patients with metastatic colorectal cancer refractory to standard therapies. However, its patterns of response has not yet been fully understood. Methods
Externí odkaz:
https://doaj.org/article/42abb434fc3546a58cd8e27315636858
Autor:
Genki Watanabe, Yoshihiro Mise, Masaru Oba, Akio Saiura, Yosuke Inoue, Yu Takahashi, Yoji Kishi, Koichi Suyama, Tadatoshi Takayama, Tamaki Noie, Yujiro Nishioka, Nobuhisa Akamatsu, Junichi Arita, Norihiro Kokudo, Kiyoshi Hasegawa
Publikováno v:
HPB. 24:1245-1251
The effect of bevacizumab plus mFOLFOX6 on downsizing of liver metastases for curative resection has not been well assessed for patients with advanced colorectal liver metastases (CRLMs). This multicenter phase II trial aimed to examine the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82df1ed2cb50405f06f0803bc12ddc0e
https://doi.org/10.1016/j.hpb.2022.02.001
https://doi.org/10.1016/j.hpb.2022.02.001
Autor:
Hiroyuki Abe, Yoichi Yasunaga, Sho Yamazawa, Yudai Nakai, Wataru Gonoi, Yujiro Nishioka, Koji Murono, Kazuhito Sasaki, Junichi Arita, Kazushige Kawai, Hiroaki Nozawa, Kiyoshi Hasegawa, Soichiro Ishihara, Tetsuo Ushiku
Publikováno v:
Human Pathology. 123:74-83
The histological growth pattern of liver metastases (desmoplastic, pushing, and replacement patterns) at the tumor-liver parenchymal interface is a prognostic factor in patients with colorectal cancer. However, data regarding its association with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b713fa68f34303f43ab24efb4cc5bfd4
https://doi.org/10.1016/j.humpath.2022.02.015
https://doi.org/10.1016/j.humpath.2022.02.015
Autor:
Meredith C. Mason, Maciej Krasnodebski, Caitlin A. Hester, Anai N. Kothari, Caeli Barker, Yujiro Nishioka, Yi-Ju Chiang, Timothy E. Newhook, Ching-Wei D. Tzeng, Yun Shin Chun, Jean-Nicolas Vauthey, Hop S. Tran Cao
Publikováno v:
Annals of Surgical Oncology. 29:5156-5164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8870acacfe49487e8fac640543ece1c2
https://doi.org/10.1245/s10434-022-11683-1
https://doi.org/10.1245/s10434-022-11683-1
Autor:
Yun Shin, Chun, Guillaume, Passot, Yujiro, Nishioka, Riham, Katkhuda, Elsa M, Arvide, Nazim, Benzerdjeb, Jonathan, Lopez, Scott E, Kopetz, Dipen M, Maru, Jean-Nicolas, Vauthey
Publikováno v:
Journal of the American College of Surgeons. 235:8-16
Micrometastases, defined as microscopic cancer cells spatially separated from the macroscopically evident metastasis, are identified in 24% to 56% of resected colorectal liver metastases (CLMs). Somatic gene mutations have emerged as independent prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266bd6be1f13b1508334ba29773699e2
https://doi.org/10.1097/xcs.0000000000000223
https://doi.org/10.1097/xcs.0000000000000223
Autor:
Eisuke Shibata, Hidemasa Takao, Masafumi Kaiume, Junichi Arita, Naoki Okura, Yujiro Nishioka, Kiyoshi Hasegawa, Osamu Abe
Publikováno v:
Minimally Invasive Therapy & Allied Technologies. 31:939-947
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2347fca3444eceef1825dc3fea89e3c4
https://doi.org/10.1080/13645706.2022.2033269
https://doi.org/10.1080/13645706.2022.2033269
Autor:
Jason Henry, David S. Hong, Saikat Chowdhury, Bryan K. Kee, Oluwadara Coker, Van K. Morris, Nikeshan Jeyakumar, Benny Johnson, Shubham Pant, Christine Megerdichian Parseghian, Jean Nicolas Vauthey, John Paul Shen, David R. Fogelman, Maliha Nusrat, Scott Kopetz, Michael J. Overman, Arvind Dasari, Yujiro Nishioka, Robert A. Wolff, Kanwal Pratap Singh Raghav, Limin Zhu
Publikováno v:
JCO Precision Oncology. :613-621
PURPOSE KRAS p.G12C mutations occur in approximately 3% of metastatic colorectal cancers (mCRC). Recently, two allosteric inhibitors of KRAS p.G12C have demonstrated activity in early phase clinical trials. There are no robust studies examining the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebbe88a6585d3f6bf61a2bfabde75cd5
https://doi.org/10.1200/po.20.00256
https://doi.org/10.1200/po.20.00256
Autor:
Hop S. Tran Cao, Natalia Paez-Arango, Jeffrey E. Lee, Jean Nicolas Vauthey, Yun Shin Chun, Timothy J. Vreeland, Timothy E. Newhook, Ching Wei D. Tzeng, Yoshikuni Kawaguchi, Federico Oppliger Boettcher, Yujiro Nishioka
Publikováno v:
Journal of Gastrointestinal Surgery. 26:791-801
BACKGROUND We evaluated the associations of surgical margin status and somatic mutations with the incidence of local recurrence (LR) and oncologic outcomes in patients undergoing R0-intent (microscopically negative margin) resection of colorectal liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f87b59935265301fd2c099ec289ae22
https://doi.org/10.1007/s11605-021-05173-0
https://doi.org/10.1007/s11605-021-05173-0
Autor:
Genki Watanabe, Junichi Kaneko, Junichi Arita, Takeaki Ishizawa, Nobuhisa Akamatsu, Takashi Kokudo, Yujiro Nishioka, Kiyoshi Hasegawa, Akihiko Ichida, Satoshi Yamamoto
Publikováno v:
World Journal of Surgery. 45:1887-1896
The aim of this prospective study was to analyze the impact of abdominal incision type on postoperative pain and quality of life (QOL) in hepatectomy. In patients undergoing hepatectomy by open, hybrid, or pure laparoscopic approaches, we classified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf7f1dcc35562ae98dc486cee1fc87c
https://doi.org/10.1007/s00268-021-05992-x
https://doi.org/10.1007/s00268-021-05992-x